Return to Academic Venture Fund
2017: Small Device, Big Results
A pocket-sized device promises health workers around the world an easy, inexpensive way to detect antibiotic resistance and manage infections–right in the doctor’s office or clinic. Partnering with Weill Cornell Medicine, the researchers will develop Rapid Identification of Antibiotic Resistance (RIDAR), a handheld diagnostic tool that delivers near-instant information about a patient’s infection type to reduce unnecessary antibiotic use. If the infection is bacterial, RIDAR will check its antibiotic susceptibility and suggest the most effective drug for treatment.